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ABSTRACT
The objective of this research was to search for an antiviral compound,
garcinol (or guttiferone F) from the Garcinia kola nuts using two different extraction
techniques and formulate a suitable liposome for control release using an antiviral
compound. The two extraction techniques used were: liquid-liquid extraction (for
simplicity purposes, the term solvent-solvent, S-S, will be used interchangeable) and
Supercritical Fluid Extraction (SFE).

Both techniques were used to profile

compounds found in Garcinia kola and for statistical comparison purposes. Extracts
from both techniques were collected and analyzed for separation using ReversedPhase High Performance Liquid Chromatography (RP-HPLC) using Ultraviolet
Photodiode Array (UV-PDA) detection, determined physical and chemical properties
by proton and phosphorus Nuclear Magnetic Resonance (1HNMR and 31P-NMR), and
quantify by Ultra Performance Convergence Chromatography (UPC2) coupled to
Quadrupole Time of Flight Mass Spectroscopy (Q-ToF/MS). The UPC2 Q-ToF/MS
data was processed using TransOmics Informatics for Metabolomics and Lipidomics
(TOIML) and statistical analysis was performed interrogating similarities and
dissimilarities of each extraction techniques. Biological assay were conducted on
three of the S-S extracts and compared to know antiviral inhibiting drugs as controls.
For the formulation study, Dynamic Light Scattering (DLS), Differential Scanning
Calorimetry (DSC) and release studies were conducted in order to characterize the
garcinol liposomes. Initial RP-HPLC results showed no compounds with photodiode
array (PDA) fingerprints characteristic of garcinol were found in either of the extracts
from both extraction techniques.

NMR confirmed what was already observed:

garcinol has the same molecular formula, weight and chemical structure as the
previously reported guttiferone F and both names (garcinol and guttiferone F) are used
interchangeable. Comparison of the different extraction techniques by UPC2 QToF/MS resulted in the identification of 1291 chemical features and the features were
grouped together statistically based on their relative extraction solvents and
techniques. Of the 1291 detectable mass constituents, 43.81% can be extracted by S-S
technique and 40.09% can be extracted by SFE technique, relatively similar extraction
profile. Approximately 20.99% of the mass constituents were detected using both
extraction techniques.

Overall, results from the SFE showed the comprehensive

profile of all mass constituents found within this natural product and each mass
grouped statistically based on their relative extraction solvents to determine extraction
coverage. In addition, these statistical analysis and extraction techniques have never
been performed simultaneously and or compared on Garcinia kola seeds. Biological
data revealed that extracts from the S-S technique was negative for the inhabitation of
antiviral activities as compare to the controls. The results of the liposome release
studies indicated initial rapid release of less than 1% of garcinol from the liposomes,
followed by a sharp drop in concentration at 4 hours, suggesting precipitation in the
dissolution medium with no further release as the concentration leveled off to 140
hours. DSC results indicated that the surface charge of the liposome was -10.5 mV
and remained relatively constant for 7 days suggesting stability issues. DLS results
indicated an increase in particle size and Polydispersity index over a 7 day period
which also suggests stability issues. Overall, the formulation study showed garcinol
released less than 1% and may interact significantly with the DPPC phosphate head

groups, as indicated by the large increase in net negative surface charge. Although no
antiviral activities were active in Garcinia kola, this edible plant could serve as an
abundant

source

of

naturally-occurring,

bioactive

pharmaceutical development for other biological activities.

compounds

for

further
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CHAPTER 1

INTRODUCTION
Garcinia kola is a species of flowering plants which grows in tropical climates
across Western Africa, Asia, and Australia. Garcinia kola belongs to the Guttiferae
(formally Clusiaceae) family.

There are more than thirty genera of Guttiferae,

including Calophyllum, Hypericum, Allanblackia, and Garcinia. (Whitmore et al.,
1973). Guttiferae is divided into three subfamilies: Kielmeyeroideae; Hypericoideae;
and Clusioideae (Gustafsson et al., 2002). Garcinia belongs to the subfamily
Clusioideae. There are well over fifty species of evergreen trees and shrubs belonging
to the Garcinia genus, including Garcinia cambogia, Garcinia indica, Garcinia
mangostana, Garcinia livingstonei, Garcinia candelliana and Garcinia kola. (Smith
et. al., 2004). Known products containing Garcinia mangostana are commonly sold
as dietary supplements in the United States under the trade name Hydroxycut TM.
There are four main classes of secondary metabolites with biological activities
found in the Guttiferae family: benzophenones; bioflavonoids; coumarins; and
xanthones. The chemical structures of several of the benzophenones contain the
polyisoprenylated benzophenone core bicyclo [3.3.1]-nonane-2, 4, 9-trione linked to a
13, 14-dihydroxybenzoyl phenyl ring is found in Figure 1 (McCandish et al., 1976).
This core structure is a common structural motif of the benzophenones which have
been isolated from plants. The benzophenones are increased in hydrophobicity per
number of prenyl functional groups attached.

1

Figure 1: General structure of
polyisoprenylated benzophenones (Acuna
et. at. 2009)

Garcinia kola has a distinct bitter taste-hence its common name “bitter kola”
and also its common name “male kola” because of its claimed aphrodisiac activity.
There is an average of four seeds contained in a fruit (Figure 2). The seeds are
extracted by breaking open the fruit. The seed contains fat, proteins, carbohydrates,
xanthones, bioflavonoids, benzophenones, and other compounds. They are chewed
for the relief of cough, colds, colic, hoarseness of voice, and throat infection (Ofokansi
et al., 2008). The fruit pulp is used to treat jaundice (Uko et al., 2001). The sap is
used for the treatment of parasitic skin diseases, while the latex is orally ingested for
the treatment of gonorrhea (Ofokansi et al., 2008) and applied to wounds to assist in
healing (Uko et al., 2001). The roots and stems are eaten as a snack food known as a
chewing stick for dental care, to suppress appetite and to aid in the digestion process.
Compounds isolated from Garcinia kola and other members of the Garcinia
genus have been shown to have useful therapeutic, bio-protective, and other biological
activities. Garcinia kola is used for the treatment of liver disorders (Adaramoye et al.,
2006). More recently, Garcinia kola has been assessed for its potential utility for
fighting infectious viral diseases, such as Ebola, by preventing viral replication (BBC
Health News, 1999). Despite its bitter taste, Garcinia kola has been traditionally
consumed for cultural, social, and traditional ceremonies, and for the worship of
2

ancestral gods. Garcinia kola has also been employed as a substitute for hops in
tropical beer (Ajebesone et al, 2004). Paradoxically, it has been claimed to cause both
nervous alertness and to induce insomnia (Uko et al., 2001). Thus, there is significant
ethnobotanical and epidemiological evidence available suggesting that Garcinia kola
is relatively non-toxic to humans when ingested or applied to the body.

Figure 2: Garcinia kola seeds (courtesy
of Google image)

The most abundant biologically active constituent in the seed of Garcinia kola
is known as kolaviron (Figure 3). Kolaviron is a mixed biflavoniod complex derived
from the defatted alcoholic extract of the plant. The complex consists of GB-1, GB-2,
and kolaflavanone) shown below in Figure 3 (Cotterill et al., 1978). The primary
difference between GB-1 and GB-2 is the replacement of hydrogen (H) with a
hydroxyl group (OH).

Figure 3: The structure of bioflavonoids: Kolaviron (courtesy of Google image)

3

Earlier work on the phytochemistry of Garcinia species resulted in the
isolation of pharmacological compounds from several chemical classes including
xanthones, bioflavonoids, triterpenes and benzophenones. Xanthones are polyphenols
that arise from the biosynthetic pathways of shikimate and acetate. A number of
xanthones are known for their anti-cancer and anti-obesity properties (Iwu et al.,
1987). The fruit hull of Garcinia mangostana possesses anti-cancer activity and this
biological effect has been attributed to xanthones. Xanthones are believed to act by
blocking inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)
expression (Wan et al., 2004). Xanthones also possess anti-inflammatory activities
(Chen et al., 2008) by the reduction of iNOS in murine macrophages. Bioflavoniods
are phenolics, a class of phytochemicals which primarily act as plant pigments and
possess antioxidant activities. Bioflavonoids have been isolated from the Garcinia
kola and are abundant in the seeds of the plant (Faromi et al., 2011). Triterpenes are
compounds comprising six isoprene units which are also precursors of steroids.
Triterpenes are found in the root bark of Garcinia polyantha and they possess
antimalarial properties (Lannang et al., 2008). Benzophenones are ketone molecules
used in perfume and medicine. Kolanone is a prenylated (addition of a hydrophobic
prenyl moiety) benzophenone isolated from Garcinia kola possessing antimicrobial
properties (Hussain et al., 1982). These chemical classes are important and they may
play a role in modulating various molecular metabolic pathways essential to human
life.

They also show the diverse functions that this natural product possesses,

suggesting many potential therapeutic and biological applications for Garcinia kola.
4

The central objective of this study is to compare two different extraction
techniques for the isolation, identification and conduct a pharmaceutical formulation
of a potential antiviral compound responsible for inhibiting viral replication from
Garcinia kola. Although there is evidence that such isolation methods can be applied
to isolate potential benzophenone antiviral compounds from related plant genera, these
particular methods have not been applied to Garcinia kola. In order to accomplish
this, the following hypotheses are made:
1. Utilize liquid-liquid extraction technique of Fuller et al.1999 for the isolation
of antiviral compound Guttiferone F (also called Garcinol) found in the
rootwood of Allanblackia stuhlmannii and applying the same extraction
technique to Garcinia kola nuts could lead to the isolation of the same
antiviral compound. In addition, profile the compounds found in this
extraction technique.
2. Utilize a second extraction technique, Supercritical Fluid Extraction (SFE) on
Garcinia kola nuts for the isolation of antiviral compound Guttiferone F (also
called Garcinol). In addition, profile the compounds found in this extraction
technique and compare both extraction techniques.
3. Formulate a representative antiviral compound into suitable liposomes for
controlled drug release.
The advantage of using both extraction techniques is to obtain a wide range of
extracted compounds found in Garcinia kola and for comparison purposes.

5

CHAPTER 2

REVIEW OF THE LITERATURE

This chapter will focus on the literature related to the published biological
activities, formulation studies conducted on Garcinia kola and other Garcinia spp as
well as two separation techniques used in the pharmaceutical industry: liquid-liquid
extraction and Supercritical Fluid Extraction (SFE).
2.1 Antiviral properties found in the Garcinia family
There are various species in the Garcinia genus which are reported to possess
antiviral properties. These species include Garcinia livingstonei, Garcinia ovalifolia
(Gustafson et al., 1992), and Garcinia mangosteen (Chen et al., 1996), among others.
The compounds responsible for the antiviral properties have been identified as
guttiferones. Guttiferones are polyisoprenylated benzophenone derivatives that inhibit
by cytopathic effects the activity of the virus responsible for HIV infection (Gustafson
et al., 1992). Most polyprenylated benzophenones isolated from these plants also
contain carbonyl, hydroxyl and other polar groups.
Perhaps the most cited naturally-occurring, Garcinia-derived benzophenone in
the literature is camboginol, also a synonym for garcinol.

Garcinol is a

polyisoprenylated benzophenone which has been recovered from Garcinia assigu, (Ito
et al., 2003) Garcinia indica (Hong et al., 2007), Garcinia purpurea (Matsumoto et
al., 2003), Garcinia banacana (Rukachaisirikul et al., 2005), Moronobea coccinea
(Marti et al., 2008), and Allenblackia monticola (Lenta et al., 2007) and assayed for
6

cytotoxicity as well as anti-bacterial, anti-viral, and anti-parasitic activities. Garcinol
has the same or even very similar structural to that of Guttiferone F (Gustafson et al.,
1992) and the names are said to be used interchangeable (Fuller et. al., 1999).
Guttiferone and related benzophenone antiviral compounds have been reported to be
isolated from Garcinia kola and other Garcinia spp. and they contain a number of
valuable biological active compounds. However, relatively few studies have been
reported describing the design and performance of Garcinia derived formulations and
drug delivery systems on its proposed antiviral properties. Accordingly, another goal
of this work is to develop a pharmaceutical formulation for the controlled delivery of a
benzophenone antiviral compound.
2.2 Natural Product Development
According to Newman et al. in “Natural Products as Sources of New Drugs
over the Period 1981-2002”, over 70% of small molecule drugs on the market are
derived from or are based on natural product sources (Figure 4). Natural product
sources listed includes: Unmodified Natural Products (N), Natural Product Derived
(ND), Natural Product Mimic (NM), Biological (B), and Total Synthesis (S*).
Though there are numerous compounds isolated from natural products, formulating
them into effective dosage form is a challenging process due to the lack of
standardization, as well as poor solubility and limited chemical and metabolic
stability. An increase in the study of components in the Garcinia genus has risen
within the past 20 years, but there have only been a few investigations conducted in
the United States and few-if any- on the isolation and formulation of compounds
purported to be responsible for their antiviral properties. Thus far, the only
7

formulation studies performed on Garcinia kola focus on the formulation of the main
constituent, kolaviron. To date, there are only two FDA approved drugs derived from
botanical preparation: Veregen which is a topical green tea extract approved in 2006
for the treatment of genital warts, and Fulyzaq (Crofelemer) an orally administered
drug approved in December 2012 for the treatment of HIV-associated diarrhea. This
implies that out of the 39 FDA approved new molecular entities in 2012, only 1 of
which is for HIV related diseases (Figure 5). Exploring this novel area of the
pharmaceutical potential of Garcinia kola may result in additional approved products
for the palliation and treatment of various pathologies.

Figure 4: Small molecule new chemical entities 1981-2008 by Newman et al. 2003
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Figure 5: FDA approved new molecular entities 1998:2012 (courtesy of FDA.gov)

2.3 Pharmaceutical formulation in Garcinia kola and Garcinia spp.
The development of effective and acceptable dosage forms for biologically
active natural product delivery, both locally and systemically, has been investigated
but it remains an important challenge due to the need to measure desirable biological
activities, the diverse physical-chemical properties of individual molecules, as well as
the lack of standardization and performance in dosage forms and delivery systems.
There are only a few cited research studies conducted proposing various formulations
of Garcinia kola constituents such as a tablet, eye drops, and a toothpaste. One of the
formulation studies reported was a study in 2004 by Onunkwo et al. describing a
compressed tablet formulation intended for use as an oral dosage form using a wet
granulation method. Dosage form parameters were evaluated (tablet weight variation,
thickness and diameter; hardness; content uniformity; friability; disintegration time
and dissolution profile) in order to measure and qualify the physical properties of the
9

tablets (Onunkwo et al., 2004).

Briefly, in their method, a chemical assay was

conducted on the dry, powdered seeds as well as the crude aqueous extract of the
seeds. Next, the powdered material (50 mg) and an aliquot part of the crude extract
(10 mg) were formulated into tablets using the wet granulation method. Extraction of
the powdered seeds was performed using ethanol as a solvent and concentrated using a
rotary evaporator, resulting in a dry mass.

After evaluating those parameters listed

above, the results indicated that the tablets had acceptable disintegration time,
dissolution, hardness and friability profiles.
A more recent study conducted in January 2010 at the Lagos University
Teaching Hospital in Nigeria emphasized that untreated increases in pressure due to
glaucoma in the eye can eventually lead to blindness. Accordingly, a new treatment
based upon Garcinia kola was developed and tested for effectiveness in glaucoma
patients. The study showed that a topical eye drop solution containing Garcinia kola
(0.5% aqueous) extract significantly reduced eye pressure in patients with glaucoma
using an intraocular dose twice a day. The design of the study used commercial
timolol 0.5% eye drops as a comparative control. Patient results showed that 47.8% ±
0.8% of test subjects showed a significant reduction in eye pressure when using
Garcinia kola as compared with a 48.2% ± 1.03% reduction in pressure in patients
using the control. It was concluded that Garcinia kola eye solution significantly
reduced eye pressure and this effect was comparable to the effect of the commercial
beta-blocking control, timolol (Adebukunola et al., 2010). While these formulation
studies underscore the utility and formulatability of certain crude Garcinia kola
preparations, a formulation study of Garcinia kola comprising one of its purported
10

anti-viral benzophenones has yet to be reported.
A published research study on the isolation and identification of antiviral
compounds was conducted by in 1999 by Fuller et al. In short, a series of HIVinhibitory prenylated benzophenones known as guttiferones A-E was previously
reported from extracts of three different genera (Garcinia, Clusia, and Symphonia)
from the large plant family Guttiferae or Clusiaceae (Gustafson et al., 1992). Fuller et
al. isolated the first member of the guttiferone F (also called garcinol) class of
polyprenylated benzophenones from the genus Allanblackia (also in the Clusiaceae
family). In this study it is hypothesized that the same or similar antiviral compounds
occur in, and may be isolated from, Garcinia kola since it is in the same genus. If the
Garcinia genus contains guttiferones A-E, there is a possibility that Garcinia kola
might also contain guttiferone F; which has yet to be isolated and identified in
Garcinia kola, which is said to have antiviral properties. It is hypothesized that, by
using the isolation methods of Fuller et al., the same or similar compounds may be
isolated from Garcinia kola. These are core to be answered by this research.
One of the most important issues that arise when formulating natural products
is poor aqueous solubility and stability. Many new chemical entities display poor
aqueous solubility. However, there are many techniques used to possibly overcome
solubility, such as nanosupensions, drug dispersion, and chemical modification.
Nanosuspensions are colloidal dispersion of particles of a drug that are stabilized by
surfactants. Nanosupensions also increases dissolution rates due to a large surface
area to unit volume ratio. Drug dispersion in carriers which include solid solutions
(solid solute molecularly dispersed in solid solvent), eutectic mixtures (fusion melt of
11

solute and solvent showing complete miscibility at or above all constituent melting
points) and solid dispersion (dispersion of one or more compounds in an inert carrier
in the solid state) (Gowthamarajan et al., 2010). To be more specific, solid dispersion
is used to improve the solubility of poorly soluble compounds, as well as mask the
taste of a drug substance, improve the disintegration of oral tablets, and reduce the
formulation particle size and thus increase the dissolution rate. This technique is
widely applied in the pharmaceutical industry. The last technique that will be
discussed for the use to overcome poor solubility is chemical modification. Some
examples of chemical modification are the formation of a salt complex and the use of
a prodrug (Mohanachandran et al., 2010).
As written in the previous paragraphs, solubility is a challenge in the
successful formulation of compounds such as the benzophenones found in the
Garcinia family. An example of this is found in the work described by Bhaskar et al.
According to Bhaskar et al., Garcinia mangosatana is proven to be active against
Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acne,
which are responsible for the outbreak of acne.

Preformulation studies using a

mixture of the aqueous extract of Garcinia mangosatana and with the excipient Aloe
vera proved to overcome poor solubility and results shows Garcinia mangosatana to
be a potential for drug delivery as a topical agent for the treatment of acne, which was
the goal of the study. Another study of Garcinia mangostana (specifically αMangostin) sought to improve the solubility and bioavailability of poorly-soluble αmangostin using solid dispersion (Aisha et al., 2011). The poor solubility of αmangostin hinders its therapeutic application by limiting its oral absorption. The study
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showed an enhancement in the solubility of α-mangostin using solid dispersion
systems. Also, further research suggests the need for a new therapeutic strategy of
HIV therapy due to the poor solubility of such compounds (Gupta et al., 2010).
Overall, the formulation of Garcinia mangostana and HIV therapies in general are
often shown to have issues of poor solubility and the utilization of a dispersion system
maybe a useful technique for enhancing solubility. Thus, it is hypothesized that if
anti-viral Garcinia mangostana constituents derived from a plant from the same
family as Garcinia kola, have poor solubility, than analogous materials derived from
Garcinia kola could also display poor solubility and be amenable to solid dispersion
or another solubility type enhancing formulation. A carrier formulation that may
protect the plant constituents from oxidation or hydrolysis, but that may also be useful
for oral or topical delivery, such as a physiologically-compatible liposome, may be a
viable formulation alternative.
In summary, there are antiviral compounds found in the Garcinia spp. There is
a need on the market for more antiviral therapeutic drugs. Research suggests that
although there are many studies of Garcinia spp. which focus on formulation, the
formulation of antiviral compound(s) from Garcinia kola is lacking. Now that we
know what types of compounds are found within the Garcinia spp., it’s important to
also look at different extraction techniques used to extract these compounds from their
natural source.
2.4 Extraction technique overview
Extraction is a broad term used in the pharmaceutical industry and it involves
the separation of medicinally active compound(s) of plants and or animals from the
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inactive components by using solvents from extraction procedures. One of the most
universal forms of extraction is brewing coffee: low molecular weight/concentration
molecule (caffeine) is removed from the high molecular weight/concentration material
(coffee bean). Another example is brewing tea which uses the same principle. This is
an example of solid/liquid extraction. On the other hand, liquid-liquid extraction is
commonly used in organic laboratory to separate and purify the desire product from a
mixture leaving behind a starting material and by-products. For example, the extracts
from plants are fairly impure therefore standardized extraction procedures is needed
for the final quality of the medicinal compound which can lead to a potential drug.
Both techniques are governed by distribution coefficient, a measure of how an organic
compound distribute between aqueous and organic phase. Distribution coefficient is
very important in drug delivery because a drug must be carried throughout the body to
its targeted site. A drug must have enough water solubility to dissolve in the blood and
organic solubility to get through the cell. Below are two extraction techniques used in
the pharmaceutical industry as well as some advantages and disadvantages for their
use.
2.4.1 Liquid-Liquid extraction
Liquid-liquid extraction/partitioning (the term solvent-solvent (S-S) extraction
will be used interchangeable) is a method in which a desire compound is pulled from
one solvent to another solvent only if the two solvents are immiscible (example oil and
water, Figure 6). The most common method of liquid-liquid extraction is using a
separatory funnel. Separatory funnels are used to extract a compound either from or
into an aqueous layer. Depending on the density of the solvent(s) repetitive use of the
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separatory funnel or another type of extractor is needed. Some advantage of using
liquid-liquid extraction includes it being the simplest form of extraction every used for
wide range of application in both chemical laboratories and pharmaceutical industries.
Other advantages include the ability to operate in a continuous mode, and the use of
two solvent phases. One major disadvantage is the use and disposal of disposal of
solvents used. In addition, this technique can be performed with simple equipment,
and its selective separation is usually highly efficient.

Figure 6: Separatory funnel (courtesy of Google image)

2.4.2 Supercritical Fluid Extraction (SFE)
Supercritical Fluid Extraction (SFE) is a technique used to separate one
component from another component using supercritical fluids as the extracting
solvent. SFE is also an alternative sample preparation method generally used to reduce
the use of organic solvents and increase sample throughput. SFEs are produced by
heating a gas above its critical temperature or compressing a liquid above its critical
pressure (Figure 7). Because of its low critical parameters (31.1ᵒC, 73.8 bar), carbon
dioxide (CO2) is the most used supercritical fluid used and is at times modified by cosolvents such as methanol and ethanol in order to overcome polarity limitations.
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Advantage of using CO2 includes its favorable physical properties, its inexpensive,
relatively safe and in abundance.

Figure 7: Phase diagram of Carbon dioxide, CO2 (courtesy of Google image)

A typical SFE system includes a CO2 source, a pump to pressurize the gas, an
oven containing the extraction vessel, a pressure regulator, an analyte collector and a
detector (Figure 8). Another advantage of using SFE is its extraction procedure
having little to no solvent residue and extraction at very low temperatures. The
rationale for the use of SFE was because of its shorter extraction time, and selective
extraction by varying temperature, pressure and or modifier.
SFE has been used for various extraction and isolation of natural products
including decaffeination of coffee, and extraction of hops, spices and tea because it is
an eco-friendly alternative to chemicals and solvents used by chemist. This is because
Chemist generate large amount of waste organic solvents which is growingly
attributed in environmental pollution and hazardous to human health. However, the
use of SFE in natural product extraction is limited to plant natural products.
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The goal of the SFE technique was to search for garcinol by performing liquidliquid extractions, and SFE extractions with CO2, modifier which included methanol,
ethanol, and isopropanol, and analyze via UPC2 coupled with Q-Tof-MS. The second
goal was to perform principal component analysis (PCA) of the SFE and S-S extracts
in order to find correlations to streamline sample prep approach, exploit TransOmics
workflows to aid visualization of data, targeted processing for garcinol, and
comprehensive processing for feature differences.

Pressure
Regulator

Detector

Collector

Oven

Extraction
vessel

Figure 8: Supercritical Fluid Extraction system (courtesy of Waters Corporation)
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CHAPTER 3

METHODOLOGY

Both separation techniques, Solvent-solvent (S-S) and Supercritical Fluid
Extraction (SFE) were conducted and analysis was performed by Reversed-Phase
High Performance Liquid Chromatography (RP-HPLC) using Ultraviolet Photodiode
Array (UV-PDA) detection, Proton and Phosphate Nuclear Magnetic Resonance
(1HNMR and

31P

NMR), and Ultra Performance Convergence Chromatography (UPC2)

coupled to Quadrupole Time of Flight Mass Spectroscopy (Q-ToF/MS). Biological
assay was conducted and compared to controls. Characterization of the liposome
formulation was performed using Differential Scanning Calorimeter (DSC) and
Dynamic Light Scattering (DLS). Lastly, the rate of release and extent of release was
conducted using dissolution tests. The follow discuss the materials and methodology
used.
3.1 Materials
Garcinia kola nuts (2 kg) were purchased from Gold Coast Trading Company
(Bronx, New York) in January 2011. Organic solvents (hexane, methanol, acetone,
dichloromethane, and methyl-tert-butyl ether (MTB) were purchased from Fisher
Scientific (Fair Lawn, New Jersey).

Sephadex LH-20 resin for size exclusion

chromatography was purchased from Sigma Aldrich (St. Louis, MO).

Potassium

phosphate monobasic and dibasic was also purchased from Sigma-Aldrich (St. Louis,
MO). The active antiviral compound Garcinol (MW 602.8) was purchased from Enzo
Life Sciences (Farmingdale, New York). For the liposome formulation study, 1, 218

Dipalmitoyl-sn-glycero-3-phosphocholine monohydrate (DPPC) was purchased from
Corden Pharma Switzerland LLC (Switzerland). Cellulose membranes (Spectra/Pro ®
Float-A-Lyzer® G2) with a molecular weight cutoff of 3500D used for drug release
tests were purchased from Spectrum Laboratories Inc. (Rancho Dominguez,
California).
3.2 Extraction techniques
The following sections include the extraction methodology employed on Garcinia
kola using the two extraction techniques mentioned above.
3.2.1 Liquid-liquid extraction
Two kilograms of Garcinia kola nuts were spread on a plastic bag and dried in
a Robertshaw Drying Oven at 135ᵒF for five days. Upon exhaustive drying, the nuts
were peeled and the peelings were kept separately for future evaluation. The nuts
were ground using a coffee grinder yielding a total of 1071 grams of ground material.
One kilogram of the ground nuts was weighed and transferred to a large glass
chromatography extraction column with a mechanical mixer. Three liters of hexane,
then three liters acetone, then three liters of methanol, and then with one liter of a
combined 1:1 methylene chloride-methanol was then introduced to the nuts
respectfully. It is important to note that one liter of solvent was added at a time, mixed
for 12 hours to 24 hours, and then removed. This entire process was monitored for
roughly six days. The seeds were also subject to other solvents including ethyl acetate
and chloroform (<250 mL each) solvent extraction scale. The various solvent systems
served as a removal vehicle of compounds found in Garcinia kola nuts. After each
successive extraction, the solvents were removed by rotary evaporation, and the
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resulting residues were labeled, sealed, covered and stored. The hexane extract was
bright yellow, and the acetone and methanol extracts reddish-brown and brownish-red,
respectively.
Next, the method described by Fuller et al., comprising solvent-solvent
extraction (hence the use of the term S-S because the rotary evaporated samples,
mentioned above were re-introduced to solvent), was applied to the initial extract
residues by combining a 5 g portion of the 1:1 methylene chloride-methanol and
methanol extracts (2.5g each). This combination was further separated by solventsolvent partitioning into hexane (200 mL), methyl-tert-butyl ether (MTB, 10 mL),
ethyl acetate, and water.

The purpose of partitioning was to ensure that the

compounds were separated based on their solubilities into two different immiscible
liquids. In short, after the portioning fraction was added to the separating funnel with
the 1:1 methylene chloride-methanol and methanol extracts combined, the funnel was
closed, shaken abruptly which lead to one phase (hexane for instance) being separated
out from the 1:1 methylene chloride-methanol and methanol extracts phase and slowly
opening the tap of the funnel and collecting each immiscible fractions.

The

partitioned hexane, MTB, ethyl acetate and water fractions were labeled, sealed with
aluminum foil and Parafilm® around the neck of the beaker, and placed in the
laboratory refrigerator in Fogarty 41.
The MTB fraction was passed through Sephadex LH-20 loaded into a glass
chromatography column using 1:1 methylene chloride-methanol as the mobile phase,
yielding 8 fractions. The third and fourth fractions were collected are noted as
(Sephadex fraction 3/4). An illustration of this protocol is further depicted in Figure 9,
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all of which were analyzed by analytical techniques in section 3.3.

Figure 9: Flow chart of Guttiferone F isolation (Fuller et al 1999)

3.2.2 Supercritical fluid extraction (SFE)
Sample preparation for the SFE experiment was performed by weighing out 1
gram of Garcinia kola nuts which were placed in empty white tea bags, the bags were
folded and stapled shut. The tea bags were placed in a metal vessel and sealed tightly.
The vessels were then loaded into the oven portion of the SFE. Valves were
connected, the instrument set with 100% carbon dioxide (CO2), and organic solvent
modifiers, including methanol (MeOH), ethanol (EtOH) and isopropyl alcohol (IPA)
5%, 10% and 30% each by w/w. Each sample collected was subjected to various
analytical methods also mentioned in section 3.3.
3.3 Analytical analysis
The following sections include the analytical analysis of samples extracted and
collected with both extraction techniques mentioned previously.
3.3.1 Reverse Phase High Performance Liquid Chromatography (RP-HPLC)
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High Performance Liquid Chromatography (HPLC) is an analytical technique
used to separate, identify and quantity components in a mixture. HPLC has been used
in various industries including medical, legal and manufacturing. With a slightly
higher operating pressure (50 bar-350 bar), it contains a mobile phase which is
typically an organic solvent, and a hydrophobic stationary phase (hence, reverse
phase) which is typically a solid absorbent material, 2-50µm in size. There are two
types of phases in chromatography: normal phase and reverse phase. The term
“reverse phase” refers to any chromatography methods that uses hydrophobic
stationary phase. HPLC separation is due to the different degrees of interaction with
the solid adsorbent material which is why it’s so widely used. Components of a
typically HPLC system includes: a liquid analyte (sample), pumps used to push the
analyte through the column, an injector, a non-destructive detector, such as phased
diode array or ultraviolet where the analytes can be recovered and a computer
analyzing system.
In brief, the analytes are prepared, injected, carried to the column by a pump
where it’s separated and lastly detected then recorded yielding a spectra which shows
the analyte’s characteristic fingerprint. The HPLC method used was an isocratic
acetonitrile-water (0.1% Glacial acetic acid) detection range from 190 to 400 nm
(baseline check at 220 nm, 230 nm, 256 nm, and 282 nm). The column used was an
Agilent Zorbax SB-C8, 250mmx4.6mm, 5µ, at a flow rate of 1 milliliter per minute
and the run time was 20 minutes. Detection wavelengths were set to collect within a
range between 200 nm to 400 nm. The Garcinia kola extracts were subject to this
isocratic method on each of the separation process found in Figure 9.
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3.3.2 Ultra Performance Convergence Chromatography (UPC2) coupled to
quadrupole time-of-flight Mass Spectroscopy (Q-Tof-MS)
Mass spectrometry (MS) is an analytical technique used to measure molecular
weights, observe elements present in a compound and provide more information about
its molecular structure. To do so, the element must be ionized (remove one or more
electrons creating a charged particle) by a magnetic field. Because of the magnetic
field, the ions in the element are accelerated so that they all have the same kinetic
energy and are measured according to their masses. There are various ways the
elements can be ionized electrospray ionizer (ESI) being the most popular. ESI works
by applying high voltage to a particle producing an aerosol of ions. ESI is great for
producing ions from macromolecules because it takes into account fragmentation of
ions. ESI is also used for producing multiple charged ions and widening the mass
range of bigger compounds like proteins and polypeptides. Most mass spectrometer
works in negative ion, ESI(-), and positive ion, ESI(+), electrospray ionization mode
depending on whether the observed ions are negatively or positively charged.
After the ionization step, the data system then reads the digital information
(mass to charge ratio, m/z) displaying it as a mass spectrum. There are also different
ways that the mass to charge ratio can be analyzed: Quadrupole mass analyzer and
Time of Flight (ToF) mass analyzer being two popular examples. As the name
implies, quadrupole has four cylindrical rods which are set in parallel. The purpose
for the quadrupole is to filter the mass based of the mass to charge ratio as electric
field is being applied to the rods. Time of Flight on the other hand, determines the
mass to charge ratio based on a time measurement, the time it takes the particle to get
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to the detector at a known distance. The time depends on the mass to charge ratio:
heavier particles takes longer and vice versa. When both the quadrupole and time-offlight mass analyzer instruments are combined and used this way, a more accurate
mass measurements and fragmentation experiments can be carried out.
Another type of chromatography used is Ultra Performance Convergence
Chromatography (UPC2). UPC2 is also an analytical technique that incorporates the
re-design of a chromatographic system using liquid carbon dioxide (CO2) as the
primary mobile phase. UPC2 uses both gas and liquid as mobile phases; hence, the
term convergence. A co-solvent or modifier, typically methanol, is used as an elution
solvent. The technique follows the principles and selectivity of normal phase
chromatography (hydrophilic stationary phase). UPC2 also uses stationary phases
consisting of smaller particle size (< 2 µm) therefore providing greater efficiencies
that results in a greater resolving power capable of separating more analytes per unit
time. UPC2 works great for improving the productivity, efficiency, and throughput of
samples. It reduces retention times, and thus processing cost, and drastically reduces
solvent usage. Alternating high and low collision energy was performed during a
single injection, a technique known as MSE, which uses two different steps of mass
spectroscopy, allowing for precursor and product ion determination. This method is
used for finding out related substances of the compound of interest. The alternating
scanning provides accurate mass measurement for all detectable ions for the system
and provides faster speed and resolution. By applying a collision energy field, MS E
can be applied in an aim to measures the molecule’s distinct fragmentation pattern
which provides structural information. Note that Base Peak Intensity (BPI) was used
24

as a trace that subtracts the background noise in the spectra. UPC2 may also be
coupled to quadrupole and time-of-flight mass analyzers (Q-Tof MS) in order to target
a broad range of compounds in complex samples. And this technology is used in
order to comprehensively acquire data, locate and identify known compounds, identify
unknown peaks of interest, and elucidate structures of unknown.

Figure 10: Workflow overview analysis (courtesy of Waters Corporation)

The workflow employed for the chemical profiling of Garcinia kola is
described in Figure 10. Extracts from the samples listed in Figure 9, were analyzed
using Waters ACQUITY UPC2 instrumentation. An ACQUITY UPC2 BEH column
with dimensions 3.0 x 100mm; 1.7um was observed as providing the best separation
with the greatest number of peaks. Ethylene Bridged Hybrid (BEH) columns are used
in small molecule to large biopharmaceutical analysis. MS data acquisition was
performed using Waters Xevo G2 Q-ToF.

Alternating high and low collision

energies, 5V and 30V, respectfully, allowed for precursor and product ion
determination as stated above.
3.3.3 Nuclear Magnetic Resonance (HNMR and 31P-NMR)
Nuclear Magnetic Resonance (NMR) is a spectroscopic technique used to
study nuclei with non-zero nuclear spins. All nuclei contain protons hence they have
charge and spin. Many nuclear spin values are possible. The most important are those
with spin ½ such as 1H and
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P that are relevant here. When these non-zero nuclear
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spin nuclei are placed in a magnetic field, two spin states form; one of higher energy
and a more abundant lower energy state. NMR is detected by observing the spins
moving between these energy states after an electromagnetic pulse. NMR can be used
to investigate molecular structure using proton

1H

NMR as well as investigate lipid

bilayer structure packing with phosphorus 31P NMR.
The result of an NMR experiments is reported as a chemical shift (δ, delta)
from a reference compound and is measured in parts per million (ppm). The 1H
chemical shift range is approximately 0 to 10 ppm (on a scale from right to left). The
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P chemical shift range is approximately 250 to -250 ppm.

1

H nuclei resonate at

different chemical shifts as a function of the electron density around them which is
dependent on the molecular structure. As the electron density surrounding the nucleus
increases, the chemical shift decreases.
1H

NMR is used to study bond connectivity which leads to identification and

information about the molecular structure. Protons in different chemical environment
have characteristic chemical shifts and these known chemical shifts can be used to
determine molecular structures. In addition to the chemical shift data, protons near each
other display the fine structure because they sense the presence of the neighboring protons
through bonding electron pathways for protons less than three bonds away. These close
connections can be determined with a Correlated Spectroscopy (COSY) experiment. COSY

data allows groups of coupled protons to be identified and then these groups are used
to build up network of protons to determine the molecular structure.
1H

NMR spectra observed the stability of the protons found in the garcinol

molecule were acquired on a 300 MHz 1H NMR spectrometer. Testing was performed
on garcinol and the hexane extract. The sample preparation comprised of dissolving 36
26

mg of garcinol and 36 mg of the hexane extract residue in 1 mL of deuterated
methanol and each placed in a 5-millimeter NMR tube. The samples were then placed
in the NMR system and results were generated and displayed as an intensity plot.
Phosphorus NMR can be used to assay purity and to assign structures of
phosphorus containing compounds. In biological applications, this approach is used to
study the lipid bilayer and membranes in various conditions. It can provide
information about lipid bilayer packing, phase transitions, and lipid head orientation.
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P-NMR spectra of DPPC liposomes were acquired on an Agilent NMRS 500

NMR spectrometer using 5mm NMRone probe operating at 202.3 MHz. The probe
temperature was set at 37 °C for all experiments. Liposome formulations analyzed by
NMR were prepared as described in section 3.5 with the exception that 10%
deuterated oxide (heavy water, D2O) in water was used as a solvent in order to provide
a deuterium lock signal. NMR data were collected for 60,000 scans with a 35.7 kHz
sweep width using 131 K data points. Acquisition time was 1.3 sec with a relaxation
delay of 0.5 sec. The data were processed with Mnova program V8.1 Mesterlab
research SL. A line broadening of 50 Hz was applied to all spectra. All spectra were
indirectly referenced to phosphoric acid (H3PO4) set to 0 ppm. Data were acquired
without spinning.
3.4 Biological Assay
Antiviral and cytotoxicity evaluation of three selected extracts of Garcinia
kola (Table 1 and Figure 9) were conducted in the laboratory of Rega Institute for
Medical Research at the University of Leuven in Belgium. The tetrazolium-based
colorimetric (MTT) assay using MT-4 cells (C8166 cells) were used for the detection
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of anti-HIV compounds. The MTT assay measures cell viability (mitochondrial
activity), if cells are viable, tetrazolium dye is reduced and undergoes a color change,
which can be detected and quantified. These tests were performed against HIV-1
(strain IIIB) and HIV-2 (strain ROD) on MT-4 cells which are Human T cells isolated
from a patient with adult T-cell leukemia which supports HIV growth. HIV-1 (strain
IIIB) was provided by the National Institute of Health and HIV-2 (strain ROD) was
provided by Pasteur Institute, Paris France. The process for the replication of the HIV
virus occurs within 5 days. In short, infected cells were cultured, treated, incubated,
and evaluated to determine the IC50s and CC50s of the extracted compounds. These
tests were carried out in quadruplicate. The 50% inhibitory concentration (IC50) was
defined as the inhibitor concentration that reduced the level of the HIV viral
expression by 50%. The 50% cytotoxic concentration (CC50) was defined as the
concentration of compound that inhibited MT-4 cell proliferation by 50%. Cell
viability was taken into account relative to controls which were: nevirapine,
lamivudine, azidothymidine, and dideoxyinosine, all of which are reverse transcriptase
inhibitors (RTi) drugs effective against HIV and are available commercially.
Code
WOR/001A
WOR/003/4

Sample
1:1 (DMC-MeOH)-Hexane partitioned in
Hexane
1:1 (DMC-MeOH)-MeOH combined

WOR/003/4
b

MTB extract

Table 1: Antiviral assay samples

3.5 Preparation of liposome formulations
Liposomes are hollow bi-lamellar or multi-lamellar spheres (vesicles) typically
comprised of physiologically compatible lipids. These membrane-like structures have
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two different phases: at low temperature (before transition temperature) rigidity occurs
as a gel-like phase and at higher temperatures (above transition temperature) a liquid
crystal phase is formed. These phases are dependent upon how the lipids in the
bilayers of the liposomes are arranged.
Liposome preparation was performed using the film rehydration method using
garcinol as an active pharmaceutical ingredient (API).

The garcinol liposomes

vesicles were prepared by dissolving 43.75 mg of DPPC in 3.5 ml of methanol (2 mM
lipid concentration). Methanol was removed by rotary evaporation at 50 ᵒC starting at
450 mbar for 30 minutes, then at 300 mbar for 30 minutes and lastly at 200 mbar for
30 minutes. As a side note, the lipids were first rehydrated in 137 mM PBS (pH 7.4)
in which garcinol degraded. From this observation, several biological buffers were
tested in the presence of garcinol in order to determine garcinol stability in the optimal
buffer solution. Results of this stability test are shown in section 4.5.5. Potassium
phosphate buffer (PPB) at pH 7.4 was selected as the most stable buffer. The lipid
film was then rehydrated with 2 mM garcinol in 50 mM PPB for 30 minutes at 50 ᵒC
above the DPPC transition temperature. Dynamic light scattering (DLS) was
performed after sonication of the hydrated lipid film to confirm the particle size and its
distribution. Finally, the liposome formulation was subject to release studies in order
to assess the rate and extent of garcinol release.
3.5.1 Sonication
After the liposomes were make, its particle size was very large. To improve
and decrease the size of the liposomes, they were carefully sonicated for 2 minutes at
50% amplitude.
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3.5.2 nano-Differential Scanning Calorimetry (nano-DSC)
Differential Scanning Calorimetry (DSC) is used to measure melting
temperature, heat of fusion, latent heat of melting, reaction energy and temperature,
glass transition temperature, and precipitation energy and temperature, denaturation
temperatures, and specific heat or heat capacity. DSC measures the amount of energy
absorbed or released by a sample when it is heated or cooled, providing quantitative
and qualitative data on endothermic and exothermic processes. DSC also measures
the degree of crystallinity as well as the drug release profile which can be used to
optimize formulation of suspensions/emulsions and predict long term stability. This is
done by the change in the heat that flows through the sample and a reference at a
certain temperature is observed as the test temperature changes. An empty aluminum
pan serves as the reference sample. Data is measured as a function of temperature,
which is typically varied over a period of several minutes
The liposome 1, 2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in Figure
11 which is a neutral phospholipid containing two palmitic acid (16-carbon saturated
chains) esterified to glycerol with a phosphate group and choline attached at the polar
end was used. The phase transition temperature of DPPC from gel to liquid crystal is
42 °C, higher than human body. DPPC is surface active and fervently forms
liposomes, with the molecule actively comprising a high compaction capacity as a
result of the free rotation and attraction of the palmitoyl tails to each other.

Figure 11: 1, 2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (courtesy of Google image)
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Analysis of the DPPC liposome was performed using a DSC Q100 from TA
Universal Instruments. Here, 300µL of the sample was weighed and placed in an
aluminum pan with a cover. The heating rate was 10 °C/min from 0 ᵒC to 180 °C
under 40 cm3/min nitrogen flow. The DSC apparatus was set equilibrated at 20 °C.
Run time was roughly 2 hours. Upon the conclusion of the sample run, 1 L of
deionized water was used to clean the DSC apparatus to ensure that there were no
liposomes left stuck in the apparatus. Data was further assessed on the instruments
software.
The same theory discussed in the previous paragraph is applicable to nano-DSC
but on a nano scale (nanometers, nm, in size). Nano-DSC was performed using a TA
Instruments Nano DSC (New Castle, DE, USA). Samples at a concentration of 0.1
mM lipid were degassed under vacuum for 30 min before loading into a 0.6 mL
capillary cell. The cell was then pressurized with nitrogen to 1 atm and equilibrated at
25 °C. The sample was scanned at 1 °C min-1 over a range of 25 °C to 60 °C.
3.5.3 Zeta potential
The fundamental states of matter are solids, liquids and gases. A colloidal system
occurs when one of the states of matter is finely dispersed in another. This effect is
evident in measuring thermal analysis by observing a particles’ zeta potential. Zeta
potential, Greek letter (ζ), ζ-potential, measures a fluid containing particle (in this case
the dispersion of the garcinol liposome) in a colloidal system. It measure the electrical
potential difference between the double layer of a particle at the slipping plane with
respect to the bulk liquid away from the interface as seen in Figure 12.

This

measurement provides detailed information about the stability of the colloidal system.
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Particles within the dispersion with a zeta potential tends to move toward the electrode
of opposite charge with a velocity relative to the amount of zeta potential. This
velocity is observed when the particle mobility is captured by the laser which is then
converted to zeta potential. A smaller molecule that has a high zeta potential (let’s say
±60 mV) means that the molecules in solution resist aggregation (electrically stable)
hence exposing charged phosphate groups. However, coagulation occurs at lower zeta
potential (±5 mV).

Figure 12: Zeta potential definition (courtesy of Google image)

There is no direct way to measure zeta potentials but there have been various
theoretical models and experimental techniques used to calculate it. A known
theoretical model used to describe the stability of a colloidal system is the DVLO
theory; named after its discoverers Derjaguin, Landau, Verwey and Overbeek. DVLO
theory states that the stability of a particle in solution depends on its total potential
energy (VT = VS + VA + VR) which consists of the total energy (VT) produced by the
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solvent (VS), total attractive forces (VA) and the total repulsive force (VR). In order to
obtain stability in colloidal systems, there should be minimal attractive force and
repulsion in order to resist the flocculation of particles. One experimental technique
used to estimate zeta potential of a particle in other words measure colloidal stability
is electrophoresis.
A small aliquot part of each formulation (17 mM DPPC) was diluted with 137
mM PBS to give a final lipid concentration of 1 mM. Zeta potential values were then
determined using a laser doppler procedure with a Malvern Instruments Zetasizer
Nano ZS at 25 °C. Air drop interference was eliminated before measuring the zeta
potential.
3.5.4 Differential Light Scattering (DLS)
Differential Light Scattering (DLS) determines the size distribution profiles of
particles in suspension. This occurs by a light (often a laser) hitting a particle (in this
case the garcinol liposome), producing an electronic distortion that is emitted in all
directions. An oscillating dipole in the electron cloud results. As the dipole changes,
energy is scattered in all directions and a fluctuating (or dynamic) intensity which
captures the size of the particle in solution is obtained. Smaller particles undergo
Brownian Motion, random motion of particles in a liquid or gas resulting from
collision molecules in the gas or liquid. And the distance between scattering changes
consistently with time.
DLS was carried out after sonication of the hydrated lipid film to confirm the
liposome particle size and its distribution. DLS measurements were performed using a
Malvern Instruments Zetasizer Nano ZS with a backscattering detector angle of 173°
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and a 4 mW, 633 nm He-Ne laser (Worcestershire, UK). For size distribution studies,
1 ml of the liposome formulations was analyzed in an optical grade polystyrene
cuvette at 37 °C. Before analysis, the samples were stored at 37 °C and then evaluated
after 24 hours.
3.5.5 Dialysis
During the film rehydration stage of liposome (vesicle) preparation, a certain
amount of PPB that was not trapped in the vesicles had dissolved garcinol in it.
Consider also that all of the garcinol might not have been entrapped and some may
still be present in the untrapped PPB. To overcome these potential barriers, the
garcinol liposomes were subjected to dialysis studies in order to remove any untrapped
drugs so that only the release of drugs from the vesicles could be accounted for. The
dialysis experiment was carried out until a constant drug concentration was obtained
and that equilibrium had been achieved in order to ensure no unentrapped garcinol was
present in the sample.
Dialysis experiments were conducted at room temperature (25 ± 0.5 °C) using
MWCO 3500 kD cellulose membranes for 24 hrs in 50 mM potassium phosphate
buffer solution with constant stirring so that any potential unencapsulated garcinol was
removed.
3.5.6 Dissolution
Extensively used in the pharmaceutical industry, dissolution studies provide
information about drug release for various dosage forms. Dissolution studies were
conducted in order to determine the garcinol release profile from the liposome
formulation. Dissolution studies are importanin in predicting the bioavailability of
34

various drug formulations. Dissolution was performed by transferring the dialysis tube
into a smaller beaker of 50 mM potassium phosphate buffer (37 ± 0.5 °C) solution at
pH of 7.4 with a magnetic stirrer at 75 rpm. As 1 ml buffer samples were collected for
analysis of 24 hrs period, the buffer was replaced with new buffer in order to maintain
a sink condition. Dissolution samples were collected at serial time points and were
analyzed for garcinol content by HPLC in order to quantify release over time.
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CHAPTER 4

RESULTS AND DISCUSSION
4.1 Liquid-liquid extraction technique results
After the extraction and fractionation of Garcinia kola as described in the
previous chapter, the samples that, based upon Fuller et al., would most likely contain
guttiferone F. were analyzed using HPLC using an acetonitrile-water mobile phase.
The samples are: methanol extract, MTB extract, Sephadex fraction 3/4 and three
other samples were also analyzed by HPLC: the hexane extract; the ethyl acetate
extract; and chloroform extract. These samples were noted as solvent-solvent (S-S).
The results obtained from the HPLC analyses are represented in the HPLC
chromatogram displayed in Figure 13.
3: 256 nm, 4 nm
StockSolution

Spectrum Max Plot
Methanol Extract

Spectrum Max Plot
MTBE Fraction

Spectrum Max Plot
Sephadex 3-4

Spectrum Max Plot
Hexane Extract

Spectrum Max Plot
Chloroform Extract

Spectrum Max Plot
Ethyl Acetate Extract

Retention Time
350

12.673

350

250

250

200

200
mAU

300

mAU

300

← Guttiferone F ↑

150

150

100

100

50

50

0

0

0

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

Minutes

Figure 13: HPLC chromatogram overlaid of each solvent-solvent extraction sample (methanol, MTB,
Sephadex 3/4, hexane, ethyl acetate, chloroform extracts) and the injection of the Garcinol standard using the
80:20 (w/w) acetonitrile-water mobile phase.

Results in Figure 13 shows the S-S samples were overlaid and compared to
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that of the garcinol standard peak. The results indicate that of the majority of the
analytes in the S-S extracted samples had a retention time before 9 minutes. The
results also indicate that none of the other extracts contained detectable analytes with
the same retention time as that of garcinol, which has a retention time roughly 12.5
minutes. This suggests that the antiviral compound of interest, garcinol was either not
present in any of the S-S extracts or was present at a concentration below the limits of
detection of the HPLC assay.
4.2 Supercritical fluid extraction (SFE) results
The goal of the SFE technique was to search for guttiferone F. via 100% CO2, 5%,
10%, 30% modifier extractions which included methanol, ethanol, and isopropanol,
and analyze via UPC2 coupled with Q-Tof-MS. The second goal was to perform
principle component analysis (PCA) of the SFE and S-S extracts in order to find
correlations to streamline sample prep approach, exploit TransOmics workflows to aid
visualization of data, targeted processing for garcinol, and comprehensive processing
for feature differences found in the next section.
Results shown in Figure 14 are of the HPLC overlaid chromatograms for each
of the SFE extractions and are compared to an injection of garcinol standard.
Synonymous to the previous section, results indicate none of the extracts contained
detectable analytes with the same retention time as that of garcinol, which has a
retention time of roughly 12.5 minutes. This also suggest that the antiviral compound
of interest, garcinol was either not present in any of the SFE extracts or was present at
a concentration below the limits of detection of the HPLC assay.
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← Guttiferone F ↑

Figure 14: HPLC overlaid chromatograms of the SFE extractions and the injection of the Garcinol
standard.

4.3 Comparison of both extraction techniques
After compiling the HPLC overlay as in Figure 13 and Figure 14, it was
determined that the compound Garcinol was not detected in any of the extracts. In an
effort to maximize our understanding of the various extraction methods employed,
comparisons were performed such to determine the amount of coverage for each
extraction technique by their mass.

Questions regarding types of analytes and

variations between the extractions became objectives in determining an appropriate
guidance for future studies and protocols for researchers performing natural product
profiling.

Data was obtained on the UPC2 coupled to Q-Tof MS by negative

electrospray mode. Plots were constructed in order to observe trends related to
components in the S-S extracts and the SFE extracts. Statistical analysis techniques
were used to determine differentiation between techniques by utilizing principle
component analysis (PCA). PCA measures statistical analysis of variability in the data
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set in order to make understanding and find a correlation. PCA and quadrant
assignment afford an opportunity to understand and appreciate the composition
similarities between fractions and extractions techniques. The results, shown in Figure
15 are split up into four quadrants denoted as 1, 2, 3 and 4. Each quadrant indicates if
the sample components are similar and associated near each other, or their extracted
masses were found to be within close proximity of each other and or overlap. An
analysis of the samples in both S-S and SFE techniques is summarized in Figure 15.
The components derived from the Sephadex fraction 3/4, MTB, and chloroform are
associated with quadrant 2, while the most of the SFE as well as hexane and ethyl
acetate components are nearly overlapping in quadrant 3 of the trend plot. Implying
that similar mass were extracted being that they are in proximity to each other. The
one extraction profile that was observed significantly different the rest of the
extraction groups was the 5% EtOH results, which is the outlier located on the bottom
right.

1

3

2

4
Outliers

Figure 15: Trend plot of solvent-solvent and SFE samples as determined by principle component analysis (PCA)
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In order to look more in detail at the SFE fraction, quantitative analysis was
performed using mass spectroscopy. Figure 16 displays the results are of the TOIML
dendrogram and abundance plot which shows an example of how a single feature of
the quantitative data which was examined and aided justification for consideration to
statistically group the S-S and or SFE. The top of the plot shows the different samples
of both extraction techniques. As observed, there are three different replicates within
the SFE 5% EtOH (left, indicated by □) and the Sephadex 3/4 (right, also indicated by
□). Implying that for this single spectrum feature at retention time 1.05 minutes and
m/z=499.2848, was grouped as being found in both the SFE (5% EtOH) and S-S
(Sephadex fraction 3/4) techniques

Figure 16: TOIML dendrogram data and abundance plot of a single feature (RT 1.05min; m/z=499.2848) found in
both 5% EtOH (left) and Sephadex fraction 2 (right) extractions.

(see Graph 1, 2 and 3). This grouping is termed chemical features. A total of 1291
individual chemical features were observed in the entire S-S and SFE samples (Figure
17, in percent), analyzed and placed into the following three categories: SFE, S-S and
neglect. Neglect represents neither of the S-S and or the SFE samples were observed
with a mass standardized normalized abundance (items under consideration) of zero
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and or below zero.

Total Feature Breakdown (1291)
Neglect
20.37%

S-S
55.46%

SFE
50.74%

Graph 1: Breakdown of the total features found in solvent-solvent (S-S) and Supercritical fluid extraction
(SFE) determined by a normalized abundance .1% based on the TOIML dendrogram data set

% S-S breakdown
100
90

% Occurance

80
70
60
50
40
30
20
10
0
Hexane

Ethyl Acetate

Chloroform

MTBE

Graph 2: Percentage breakdown of the total features found in S-S extracts as observed.
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Graph 3: Percentage breakdown of the total features found in SFE extracts as observed.
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Graph 4: Garcinol (bottom) in comparison to other solvent-solvent extracts (chloroform, Sephadex 3/4, hexane,
MTB, and ethyl acetate, respectfully. Results indicate no presence of garcinol in any S-S fractions.
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IPA 10%

IPA 5%

CO2
Graph 5: UPC2/MSE ES– BPI MS traces of the IPA (30%, 10%, and 5%) SFE and 100% CO2 extractions from
the top to the bottom. Garcinol was not observed to be present in these or any of the other SFE extractions
with MeOH and EtOH

MeOH 30%

MeOH 10%

MeOH 5%

CO2

Graph 6: UPC2/MSE ES– BPI MS traces of the Methanol (30%, 10%, and 5%) SFE and 100% CO2 extractions
from the top to the bottom. Garcinol was not observed to be present in these or any of the other SFE
extractions with IPA and EtOH

The results of the 1291 features in Graph 1, 20.67% are neglected. Of the remaining
detectable compounds indicated, 50.74% of the extracted compounds can be extracted
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by SFE technique and 55.46% can be extracted by S-S technique indicating both
extraction techniques nearly extract the same amount of compounds/masses. Of the
55.46% extracted by S-S, majority was extracted using the Sephadex fraction, as
shown in Graph 2.

Likewise, of the 50.74% extracted by SFE, the majority was

extracted by the use of 5% EtOH modifier, as shown in Graph 3. In addition, 26.6% of
the abundant features are extracted by both extraction techniques (not shown). Results
for garcinol standard indicate a broad UPC2 chromatography peak eluting at 4.0
minutes. Mass accuracy of the garcinol standard by ESI(-) was measured to be 1.3
ppm. Results of the S-S and SFE techniques indicated no presence of garcinol in any
extract when based on ESI(-) located in Graph 4-6. The SFE fraction of EtOH was not
shown for simplicity purposes; it too, indicated no presence of Garcinol based on
ESI(-). Garcinol was not found in Garcinia kola when following the extraction
procedure described in the Fuller et al. publication. However, common ESI(-) m/z
components found in all extracts in Graph 4 to 6 were m/z=425.26 and m/z=365.17.
The observation of these common components could further provide a more insight
into the extracts within Garcinia kola.
Next we examined garcinol at high and low collision energy as well as
molecular fragmentation of garcinol. Figure 17 and Figure 18 represents that data.
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Low Collision Energy: 5 V

High Collision Energy: 30 V

Figure 17: Garcinol MSE data at high and low collision energy with BPI trace.

Garcinol

Figure 18: MSE precursor and product ion data: major fragment used to confirm the presence of Garcinol.

45

The purposes of these experiments were to detriment the parent ion
information at low CE and then get fragmentation data from the high CE. From the
fragmentation data, we can use the spectra to look for common fragment ions in the
spectra of other detected peaks. The four major fragments of garcinol are: m/z109, m/z
409, m/z 465, and m/z 273. Although not shown, UPC2/MSE ES-BPI MS trace of
garcinol standard confirms a mass accuracy for the elemental composition of Garcinol
(C38H49O6). Retention time observed to be 4 minutes (Figure 17). The four major
fragment ions (Figure 18) were used to confirm if garcinol presence were found in the
extracted samples all of which came back negative.
4.4 Biological Study
The results for the cell-based, MTT anti-viral assay are listed in Table 2. The
three Garcinia kola extracted samples tested were completely inactive against both
HIV-1 (strain IIIB) and HIV-2 (strain ROD). The extracted samples have a high
cytotoxicity CC50 values >60 µg/ml as compared to the control lower CC50 values >20
µg/ml. These data are consistent with the HPLC and MS data which also suggest that
garcinol is not present in any of the extracted compounds (S-S and or SFE); if indeed
garcinol is an active in vitro antiviral agent.
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Code

IC50(µg/ml)

Strain Exp_nr

WOR/001A

IIIB P3.5554
P3.5556
ROD P3.5555
P3.5557
WOR/003/4
IIIB P3.5554
P3.5556
ROD P3.5555
P3.5557
WOR/003/4B
IIIB P3.5554
P3.5556
ROD P3.5555
P3.5557
BOE/BIRG587
IIIB P3.5544
= Nevirapine
P3.5546
P3.5549
P3.5551
ROD
CLO/3TC
IIIB P3.5546
=Lamivudine
P3.5551
ROD P3.5547
P3.5552
DDN/AZT
IIIB P3.5544
=azidothymidine,
P3.5546
zidovudine,
P3.5549
retrovir©
P3.5551
ROD P3.5545
P3.5547
P3.5550
P3.5552
DDN/DDI
IIIB P3.5544
= dideoxyinosine,
P3.5549
didanosine
ROD P3.5545
P3.5550

>
>
>
>
>
>
>
>
>
>
>
>
=
=
=
=
>
=
=
=
=
=
=
=
=
=
=
=
=
=
=
=
=

67
59.7
54.8
60.7
125
164
125
172
125
138
125
134
0.027
0.0242
0.028
0.0297
4
0.423
1.36
1.75
5.37
0.00193
0.00165
0.00193
0.00189
0.00187
0.00162
0.00132
0.00168
2
3.12
1.92
2.62

CC50(µg/ml)
=
=
=
=
>
=
>
=
>
=
>
=
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>

67
59.7
54.8
60.7
125
164
125
172
125
138
125
134
4
4
4
4
4
20
20
20
20
25
25
25
25
25
25
25
25
50
50
50
50

SI
<
<
<
<
X
<
X
<
X
<
X
<
>
>
>
>
X
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>

Max Prot(%) Appr. av.IC50(µg/ml) SD

1
1
1
1
1
1
1
1
1
1
1
1
148
165
143
135
1
47
15
11
4
12948
15110
12979
13242
13386
15479
18955
14857
25
16
26
19

5
1
1
1
1
0
1
15
6
6
7
10
121
136
119
112
0
93
81
96
97
90
88
80
88
94
97
91
91
104
115
100
116

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

av.CC50(µg/ml) SD

SI

>60.55

60.55

5.01

<1

>60.55

60.55

5.01

<1

>168.00

168.00

5.66

<1

>168.00

168.00

5.66

<1

>136.00

136.00

2.83

<1

>136.00

136.00

2.83

<1

0.027
>4.00

0.002

>4.00
>4.00

>147
X1

0.89

0.66

>20.00

>22

3.56

2.56

>20.00

>6

0.0019

0.0001

>25.00

>13514

0.0016

0.0002

>25.00

>15408

2.56

0.79

>50.00

>20

2.27

0.49

>50.00

>22

Table 2: Antiviral study of Garcinia kola extracts (1:1 methylene chloride/methanol-methanol, 1:1 methylene
chloride/methanol-hexane, and MTB) versus controls (Nevirapine, Lamivudine, Azidothymidine, and
Dideoxyinosine)

4.5 Garcinol formulaiton study
The following are the results represent the antiviral formulation studying where
Garcinol acts as the active pharmaceutical ingredient.
4.5.1 Zeta potential
The surface charge was measured through Zeta potential measurements and the results
predicting the stability of the colloidal system below in Graph 7.
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Graph 7: The results of surface charge through Zeta potential measurement

Zeta potential measurement provides detailed information about the cause of
dispersion, aggregation or flocculation which can be used to improve the formulation
of dispersions, emulsions and or suspensions. Results indicate a fairly consistent and,
as compared to bare DPPC liposomes, negative surface charge for seven days in
storage. The negative charge indicates that more phosphate head groups are exposed
on the surface of the liposome as compared to that of the blank DPPC liposome (not
shown), with a Zeta potential at -0.5mV. This reveals that garcinol may strongly
interact with the phosphate head groups of DPPC, perhaps exposing the negatively
charged phosphate groups to the surface and an average of -14 mV for day 3 to 7
indicating an incipient instability of the DPPC-containing liposomes.
4.5.2 Differential light scattering (DLS) results
DLS was used as a non-destructive method to characterize the size and size
distribution of the garcinol liposomes in solution, in this case a biological buffer,
(potassium phosphate buffer, pH 7.4). The results from DLS analysis of particle size
are shown in Graph 8. The results suggest that Brownian motion (diffusion constant)
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of the liposomes in solution causes the laser to scatter at different intensities. The
intensity fluctuation produces the velocity of the Brownian motion resulting in the
calculation of the particle size which is related to the hydrodynamic radius. Results
indicate an increase in the liposome size over seven days. Results also indicate
garcinol liposome is stable the first three days. At day five, aggregation starts to
occur.

Garcinol Particle Size
600

Particle size (nm)

500

N=3

400
300
200
100
0
0

Day 1

Day 3

Day 5

Day 7

Graph 8: Garcinol particle size results

Next, the result in Graph 9 summarizes the Polydispersity index (PDI) of the
garcinol liposomes. PDI takes into account the difference in size of the garcinol
liposomes in solution, or distribution profile.

The average PDI of the garcinol

liposomes over a period of seven days was 0.024. There was also an increase in PDI
over the seven days. The PDI results are consistent with the particle size data
suggesting stability is enhanced the first three days at lower PDI. This lower PDI
value means that there was a relatively small particle size distribution and
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homogenous liposomal formulations and that the liposomes in solution were relatively
stable over the course of the experiment.
Garcinol Polydispersity Index
0.50
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Graph 9: Garcinol Polydispersity index results

4.5.3 Nano-Differential Scanning Calorimetry (nano-DSC) results
DSC measures the transition temperature of the polymer in comparison to the
polymer with garcinol. Results from the nano-DSC study are in Graph 10.

Transition temperature
0.009
0.008
Heat Flow (kcal)

0.007
0.006
0.005
0.004

Garcinol Liposomes

0.003

Blank DPPC

0.002
0.001
0
-0.001 30 32 34 36 38 40 42 44 46 48 50 52 54
Temperature ᵒC

Graph 10: Results of phase transitions through DSC measurements of blank DPPC liposomes and DPPC garcinol
liposomes
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Results from Graph 10 indicate an ideal exothermic reaction with the blank
DPPC. An important characteristic of transition temperature depends on molecular
weight. The transition temperature of DPPC is 43.3 ○C and molecular weight is
734.039 g/mol whereas the molecular weight of garcinol is 602.8 g/mol. Because of
this, results show a slight polymer degradation with a lower transition temperature
(41.6○C) when garcinol is added to the DPPC liposomes. A slightly higher polymer
being combined with a smaller molecular weight API, leads to a lower transition
temperature for the garcinol formulation.
4.5.4 Nuclear magnetic resonance (1HNMR and 31P-NMR) results
The results in Graph 11 shows a proton NMR spectrum of Garcinol and
Hexane, overlaid. This

1H

NMR spectrum was conducted in order to determine the

structure of both Garcinol and hexane extract as well as to see if they overlap. Results
indicate that although there are areas of the same hydrogen 1 nuclei within both
extracts, the structures does not overlap so we can conclude that garcinol is not found
within the hexane extract. A complete chemical shift analysis of garcinol as compared
to that of guttiferone F as stated in Fuller et al, shows that both compounds are
relatively the same compounds called by different names as in Table 3.
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Atom
Position
6
7
7
12
15
16
17
18
20
21
22
23
24
25
27
28
32
33
34
35
37
38

Chemical
Shift (Δ)
Guttiferone
F
1.49
2.24
2.04
7.19
6.68
6.96
2.71
5.03
1.73
1.69
1.15
0.99
2.02
4.87
1.65
1.49
4.45
1.58
2.01
5.03
1.65
1.57

Chemical
Shift (Δ)
Garcinol
1.46
2.22
2.00
7.16
6.57
6.94
2.68
5.00
1.70
1.66
1.12
0.96
2.03
4.83
1.62
1.47
4.43
1.55
2.00
5.00
1.62
1.55

Difference
0.03
0.02
0.04
0.03
0.11
0.02
0.03
0.03
0.03
0.03
0.03
0.03
-0.01
0.04
0.03
0.02
0.02
0.03
0.01
0.03
0.03
0.02

Table 3: 1HNMR chemical shift comparison of Garcinol and Fuller et al. 1999 Guttiferone F

The results in Graph 12 show a shielding of the phosphate nuclei of the
garcinol liposome phospholipids, causing a slight change in transition temperature
with a large tail. Based upon the NMR data, the orientation of the blank liposome
phosphate head groups are saturated within the bilayer of the liposome, whereas the
split NMR peak suggests orientation at the surface of the bilayer. With these
interactions, results remain consistent with Zeta potential and DSC showing an issue
with stability of the formulation.
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Graph 11: 1HNMR spectrum of garcinol in red and hexane extract in black.

(b) Garcinol with DPPC

(a) Blank DPPC

Graph 12: Phosphorus NMR results of: (a) blank DPPC liposomes versus (b) garcinol DPPC liposome

4.5.5 Formulation study
In order to select the appropriate biological buffer for producing DPPC
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liposomes wherein garcinol would be stable, an HPLC stability study was conducted
using garcinol in the presence of various biological buffers. This was conducted in
order to select the best, non degrading buffer solution that garcinol would be stable in.
The biological buffers used were: 137 mM phosphate buffer saline (PBS); 0.9%
sodium chloride (NaCl); 5 mM sodium phosphate; 5 mM sodium chloride; 5 mM Tris
(hydroxymethyl aminomethane); 5 mM sodium citrate; and 50 mM potassium
phosphate (PPB) all at pH=7.4 while using the previously developed acetonitrile:water
isocratic HPLC method for analysis. The HPLC chromatograms for each buffer
system were as shown in Figure 19 to Figure 30.

Figure 19: 137 mM Phosphate buffer solution initial.
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Figure 20: 137 mM Phosphate buffer solution 19 hours.

Figure 21: 137 mM Phosphate buffer solution 44 hours.

Figure 22: 5mM Sodium chloride initial.
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Figure 23: 5 mM Sodium chloride 31 hours.

Figure 24: 5 mM Tris initial.

56

Figure 25: 5 mM Tris 31 hours.

Figure 26: 5 mM Sodium citrate initial.
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Figure 27: 5 mM Sodium citrate 32 hours.

Figure 28: 50 mM Potassium phosphate.
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Figure 29: 50 mM Potassium phosphate 85 hours.

Results in Figure 19 to Figure 29 show the injection of garcinol has a retention time of
roughly 12.5 minutes. However, a number of degradants increased in size and were
observed in the various buffer systems at about 7-9 minutes. The concentrations also
increased over time in several buffer systems. Accordingly, potassium phosphate
buffer solution was selected as the suitable liposome hydration medium for
formulating garcinol in DPPC liposomes.
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The results of liposomal garcinol formulation are summarized in Graph 13 and 14
below.

Garcinol calibration curve with 50mM
Potassium Phosphate Buffer
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Graph 13: Garcinol calibration curve with 50 mM Potassium Phosphate Buffer solution.

Garcinol Liposome Dialysis
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Graph 14: Garcinol dialysis release study.
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20

Graph 15 shows the garcinol HPLC calibration curve indicating a 97.26% linear trend
line of concentration versus area under the curve. In order to study the release of the
garcinol formulation, a dialysis study was conducted as seen in Graph 14. Over the 24

Area (counts)

Garcinol Liposome Dissolution
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Graph 15: Garcinol dissolution release study.

hour period, there was an increasing trend in concentration of the dialysis study.
Garcinol released over time during the 24 hours was proportional to time. In the
dissolution study, results in graph 15 indicate a fast release follow by a sharp (65%)
drop in concentration after 4 hrs, perhaps due to saturation and precipitation of
garcinol in solution. Given the high affinity of garcinol for DPPC lipid, a significant
amount of garcinol might still be present in the bilayers.
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CHAPTER 5

CONCLUSION
In this research, Garcinia kola was extracted using two different extraction
techniques: liquid-liquid (same as solvent-solvent, S-S) and supercritical fluid
extraction (SFE). Both techniques have their advantages and disadvantages. The
extracts from each technique were subjected to analysis in order to isolate, identify
and formulate garcinol, a reported antiviral compound present in related plants.
Garcinia extracts were also assayed for antiviral activity which was not observed in
vitro. SFE extracts chemical compounds from Garcinia kola seeds using carbon
dioxide instead of organic solvent as in HPLC. In the SFE technique, three different
modifiers were used (IPA, EtOH, MeOH) and in the S-S techniques, methanol, MTB,
Sephadex, hexane, ethyl acetate and chloroform were used. Both extraction techniques
were compared and analyzed by HPLC, UPC2 coupled to Q-Tof MS and compared
using statistical analysis via PCA. PCA and dendrograms were used as visual aids to
understand the different groupings, relevant use data, and understanding of the
extraction coverage. Results indicated no presence of garcinol in any extract. The
results indicated both techniques relatively extracted the same percent of extracts,
50.40% and 55.49% respectfully. In addition, 26.6% of the abundant mass features
were extracted in both the SFE and S-S extracts meaning they overlapped in the
compounds extracted. Both techniques serve as a means for complete chemical
profiling of compounds. The compound of interest garcinol, was fragmented in a
collision cell and that result yield structural information of four fragmented ions.
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Although garcinol was not present in both the extraction techniques mentioned
above, the aim of this research was to formulate an antiviral compound. garcinol,
available commercially and found in other Garcinia spp., was used as a reference
standard for comparative means. Based upon the methods and techniques employed,
it was determined that garcinol was not isolated from Garcinia kola in detectable
amounts. Garcinol was used as a model compound for a representative liposomal
formulation which was prepared and characterized. Preformulation experiments were
conducted in order to identify an appropriate physiological buffer for preparing the
liposomes, as it was found that garcinol was unstable in several representative buffer
systems as well as release studies.
Garcinol liposome were made using DPPC which is widely used to study
liposomes.

H

NMR and 31P-NMR analysis were performed for particle size separation

as well as to observe the amount of hydrogen and phosphorus, in the garcinol
compound. The proton NMR confirmed that garcinol and guttiferone F is relatively
the same compound and both names are used interchangeable. Phosphorous NMR
observed any shielding effect of the garcinol liposomes. Nano-DSC studies were
performed for the transition temperature of the liposome lipid component (DPPC)
blank and to predict the transition temperature of the garcinol liposomes. Results
indicated a lower transition temperature in the garcinol-DPPC formulation. DLS
studies were performed in order to characterize the size and size distribution of the
garcinol-DPPC liposome. The results indicate a uniform shape after sonication as well
as an increase in size over time (7 days) which could be an indicator of stability issue.
Zeta potential was conducted for the characterization of the surface charge of the
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vesicles. The results showed that garcinol had a strong interaction with the phosphate
head groups in the DPPC vesicles which may cause stability issues of the garcinol
formulation. Both dialysis and dissolution study show garcinol was released in the
DPPC liposome although in very small quantities.
In conclusion, most of the applied techniques mentioned above including SFE,
nano-DSC, UPC2 coupled to Q-Tof MS, 31P-NMR and liposomal formulation have not
previously been performed on Garcinia kola preparations or garcinol. This research is
original, innovative and multidimensional. Although Garcinia kola fractions did not
inhibit HIV virus as compared to the controls, the techniques used in this research is
trendsetting in the investigation of antiviral compounds found in Garcinia kola.
Further investigation (structural elucidation for example) is necessary in order to
identify the exact compound that corresponds with the common mass mentioned
above. In addition, analyzing the mass of the compound in positive mode would also
be useful in a more complex analysis.

Overall, both extraction techniques are

complementary and may be necessary to achieve a comprehensive profile of the
constituents found within Garcinia kola nuts and other natural products. Another
future study suggestion includes further separating the extract in the S-S technique as
well as the modified in the SFE technique which contained the largest number of
detectable compounds and applying statistical analysis.

Lastly, isolating other

biological activities in those extracts including antibacterial and or antifungal would
show the diversity of this plant natural product. With Garcinia kola, the possibilities
are endless.
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